The decline in diagnostic M&A activity is reflective of what’s been happening across the entire healthcare industry, with deals from down 20% during Q2, as compared to Q1 2020, according to consulting firm SOLIC Capital. The dip is even more pronounced on a year-over-year basis, with a decrease of 34%, only 322 M&A transactions in…
One Blockbuster Dies and Another Arises as Sluggish Deal Making Continues
The decline in diagnostic M&A activity is reflective of what’s been happening across the entire healthcare industry, with deals from down 20% during Q2, as compared to Q1 2020, according to consulting firm SOLIC Capital. The dip is even more pronounced on a year-over-year basis, with a decrease of 34%, only 322 M&A transactions in […]
